INNOVATION PHARMACEUTICALS INC. Finite-Lived Intangible Assets, Net
INNOVATION PHARMACEUTICALS INC. had Finite-Lived Intangible Assets, Net of $1.91 million as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2023-11-20
- 2023-09-30: Finite-Lived Intangible Assets, Net $1.91M.
- 2023-06-30: Finite-Lived Intangible Assets, Net $2.00M.
- 2023-03-31: Finite-Lived Intangible Assets, Net $2.08M.
- 2022-12-31: Finite-Lived Intangible Assets, Net $2.16M.
| Period end | Finite-Lived Intangible Assets, Net | Finite-Lived Intangible Assets, Net as first filed |
|---|---|---|
| 2023-09-30 | $1.91M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $2.00M 10-Q · filed 2023-11-20 | |
| 2023-03-31 | $2.08M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $2.16M 10-Q · filed 2023-02-15 | |
| 2022-09-30 | $2.22M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.31M 10-K · filed 2023-09-28 | |
| 2022-03-31 | $2.52M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $2.61M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $2.68M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $2.75M 10-K · filed 2022-09-28 | |
| 2021-03-31 | $2.83M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $2.92M 10-Q · filed 2021-02-22 | |
| 2020-09-30 | $2.97M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $3.06M 10-K · filed 2021-09-27 | |
| 2020-03-31 | $3.12M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $3.20M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $3.27M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $3.34M 10-K · filed 2020-09-14 | |
| 2019-03-31 | $3.41M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $3.48M 10-Q · filed 2019-02-08 | |
| 2018-09-30 | $3.71M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $3.78M 10-K · filed 2019-09-30 | |
| 2018-03-31 | $4.03M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $4.10M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $4.14M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $4.21M 10-K · filed 2018-09-11 | |
| 2017-03-31 | $4.29M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $4.18M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $4.25M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $4.31M 10-K · filed 2017-09-11 | |
| 2016-03-31 | $4.99M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $5.03M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $4.96M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $5.02M 10-K · filed 2016-09-13 | |
| 2015-03-31 | $5.11M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $5.15M 10-Q · filed 2015-02-09 | |
| 2014-09-30 | $5.07M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $4.96M 10-K · filed 2015-09-11 | |
| 2014-03-31 | $4.56M 10-Q/A · filed 2014-05-16 | |
| 2013-12-31 | $4.65M 10-Q · filed 2014-02-10 | |
| 2013-09-30 | $4.70M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $10.00K 10-K · filed 2014-09-15 | $10.40K 10-K · filed 2013-09-30 |
| 2013-03-31 | $3.68K 10-Q · filed 2013-05-20 | |
| 2012-12-31 | $2.85K 10-Q · filed 2013-02-13 |